Characterizing the long-term PM2.5 - mortality response function: Comparing the strengths and weaknesses of research synthesis approaches
Neal Fann*, Elisabeth Gilmore & Katherine Walker*
* Usual institutional disclaimers 1
Characterizing the long-term PM 2.5 - mortality response function: - - PowerPoint PPT Presentation
Characterizing the long-term PM 2.5 - mortality response function: Comparing the strengths and weaknesses of research synthesis approaches Neal Fann*, Elisabeth Gilmore & Katherine Walker* 1 * Usual institutional disclaimers Why study PM
* Usual institutional disclaimers 1
Source: http://www.whitehouse.gov/sites/default/files/omb/inforeg/2013_cb/draft_2013_cost_benefit_report.pdf.
total ann. (2002-2012) in billions $ 2
Costs vs. Benefits 1990 – 2020
(Section 812 Prospective Analysis)
3
4
100 200 300 400 500 600
Number of papers in Pub Med
Year Published All other Epidemiologic studies
Harvard 6-City Study (Dockery 1993) ACS study ( Pope et al. 2002) ACS study ( Pope et al. 1995)
5
100 200 300 400 500 600
Number of Published papers in Pub Med
Year Published All other Epidemiologic studies
HEI reanalysis 6C &ACS study (Krewski, 2009) Harvard 6-City Study (Dockery 1993) ACS study ( Pope et al. 2002) ACS study ( Pope et al. 1995) Harvard 6-City Study (LePeule, 2012)
6
No information Perfect information More Judgment More Knowledge 7
8
9
10
Studies available pre- 2006 (available to expert elicitation) Updates to pre- 2006 studies and new studies available up to mid-2013 Pooled hazard ratios % change in risk per 10 ug/m3 11
Broad Questions Attributes How valid are the methods and results?
How transparent are the methods and results?
inputs and results
How suited is are the data, methods, and results to the policy problem?
How suited is the method to the user needs and resource constraints?
12
13
14
15
16
17
* Results for IER analysis not yet available 18
19